Heart Failure Drug-Device Combination to Use Medtronic Technology

A drug-device combination bankrolled by Medtronic and developed by Nile Therapeutics completed dosing its first patient in Part B of an ongoing Phase I study of cenderitide, a peptide treatment for heart failure.
Med City News